glp 1 receptor agonists incretin mimetics Clinical Focus on GLP-1 in Type 2 Diabetes Mellitus Letter: Association Between Incretin Mimetics
Description
Fifthly, we applied a range of upper (and corresponding lower) truncation cut-off thresholds (no truncation, 0.1 and 99.9

Peng S, Xu J, Ruan W, Li S, Xiao F

B.GoldbergerZ

2 The administration of GLP-1 agonists (GLP-1As) can sufficiently replace the action of incretins and lower glucose levels

10.1039/d4fo01059k 102 TolhurstG.HeffronH.LamY
69705-5/asset/079012c9-a24f-4391-ba39-2f5d03668f6f/main.assets/gr1_lrg.jpg)
They are most prevalent during or shortly after dose escalation and decrease afterwards
